UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 1-U
CURRENT REPORT PURSUANT TO REGULATION A
Date of Report (Date of Earliest Event Reported):
January 30, 2026 (January 21, 2026)
| Standard Dental Labs Inc. |
| (Exact name of issuer as specified in its Certificate of Formation) |
| |
| |
| Nevada |
88-0411500 |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
| |
|
| |
|
| 424 E Central Blvd #308, Orlando, FL 32801, USA |
| (Full mailing address of principal executive offices) |
| |
| |
| 407-789-1923 |
| (Issuer’s telephone number) |
(Title of each class of securities issued pursuant
to Regulation A)
Item 8. Certain Unregistered Sales of Equity
Securities
On January 21, 2025, the Company closed a private
placement of a convertible note of the Company to an investor with whom the Company had a pre-existing relationship. Pursuant to the private
placement the Company issued $200,000 in principal amount of a convertible note of the Company (the “Convertible Note”)
in consideration of payment by the investor to the Company of the cash purchase price of $200,000. Ninety (90) days following the date
of issuance, the principal plus any accured and unpaid interest of the Convertible Note is convertible, in whole or in part, at the option
of the holder into shares of common stock of the Company at a conversion price of $0.06 per share. The Convertible Notes were issued to
the investor pursuant to Rule 506(b) of Regulation D under the Securities Act and Section 4(a)(2) thereof.
SIGNATURES
Pursuant to the requirements of Regulation
A, the issuer has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
STANDARD DENTAL LABS INC.
By: /s/ James D. Brooks
James D. Brooks
President
Date: January 30, 2026